The authors looked only at TIMI 11B patients for whom data on aPTT had been collected (n=1893) and compared the number of events and bleeding rates after 48 hours in patients on UFH to patients ...

Anti-coagulation drugs found to have different effects in diabetics after heart attack ... leads researchers from Duke University Medical Center to recommend the drug enoxaparin, ...

Six percent of fondaparinux patients developed VTEs by day 11, compared to 8% of enoxaparin patients, but by day 49 fewer enoxaparin patients than fondaparinux patients had symptomatic VTE (1% ...

The optimal strategy for thromboprophylaxis after major joint replacement has not been established. Low-molecular-weight heparins such as enoxaparin predominantly target factor Xa but to some exten ...

A total of 3604 patients underwent randomization; 1809 patients were assigned to receive rivaroxaban, and 1795 to receive enoxaparin. Major venous thromboembolism occurred in 4 of 1661 patients (0 ...

Among over 17,000 patients, the more selective enoxaparin protocol was associated with a reduction in wound hematomas compared with the original standard protocol (0.3% vs 0.7%; adjusted OR 0.38 ...

At day 10, the researchers found that 2.7 percent of the rivaroxaban group and 2.7 percent of the enoxaparin group experienced asymptomatic proximal or symptomatic venous thromboembolism (relative ...

Eye - Total hyphema following postoperative enoxaparin (Clexane) ... The drugs act on the different limbs of the Coagulation Cascade and intersect at Factor X. Warfarin takes 5–7 days for peak ...